FDA GRANTS ACCELERATED APPROVAL TO IBERDOMIDE WITH DARATUMUMAB AND HYALURONIDASE-FIHJ AND DEXAMETHASONE FOR MULTIPLE MYELOMA

Reuters · 2d ago

Please log in to view news